European drug discovery informatics market is projected to grow at a significant CAGR during the forecast period (2020-2026). The growing research activities such as the implementation of pilot projects related to the Drug Supply Chain Security Act in the region are further supporting the growth of the European drug discovery informatics market. In February 2019, a consortium of various universities including Frankfurt University of Applied Sciences, RheinMain University of Applied Sciences, Fulda University of Applied Sciences, and operational partners including Bayer AG, Boehringer Ingelheim Pharma GmbH & Co. KG, and GEFCO Forwarding Germany GmbH has developed a validated web-based platform called MYTIGATE.
Browse the full report description European Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), by End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/europe-drug-discovery-informatics-market
Moreover, the adoption of AI technology by the various pharmaceutical companies for the drug discoveries further offers ample opportunity to the market. For instance, in November 2016, Janssen Pharmaceutical NV partnered with BenevolentAI Ltd. BenevolentAI Ltd. licensed the right to develop, manufacture, and commercialize clinical-stage drug candidates from Janssen after using artificial intelligence to identify untapped potential in Janssen's portfolio. In May 2018, Roche starts working on drug discovery using AI with Owkin. Therefore, the significant presence of the major pharma companies that are actively engaged in drug discovery along with the adoption of AI analytics solutions in the country is anticipated to drive the growth of the market in Europe.
Market Coverage
Report Elements |
Details |
Study Period |
2019-2026 |
Base year |
2019 |
Forecast period |
2020-2026 |
Segments Covered |
By Function and by End-User |
Regions Covered |
UK, Germany, France Italy, Spain, and the Rest of Europe |
Key Companies Profiled |
Accenture PLC,
Dassault Systèmes SE, Eurofins GSC Lux SARL, Evotec SE, Selvita S.A, and
others. |
Key questions addressed by the report
o Recovery Timeline
o Deviation from the pre-COVID-19 forecast
o Most affected region/segment
o Recommendations
European Drug Discovery Informatics Market – Segmentation
By Function
By End-User
European Drug Discovery Informatics Market – Segmentation by Geography
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/europe-drug-discovery-informatics-market